Compare XGN & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XGN | RMMZ |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.5M | 124.8M |
| IPO Year | 2014 | 2021 |
| Metric | XGN | RMMZ |
|---|---|---|
| Price | $3.26 | $14.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 341.3K | 19.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.99 | N/A |
| Revenue Next Year | $11.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.80 | $13.79 |
| 52 Week High | $12.23 | $15.72 |
| Indicator | XGN | RMMZ |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | 43.43 |
| Support Level | $3.15 | $14.74 |
| Resistance Level | $4.00 | $14.84 |
| Average True Range (ATR) | 0.30 | 0.22 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 25.51 | 32.50 |
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.